Vanguard disaggregates holdings; INGN shows 0 shares (INGN)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
The Vanguard Group filed Amendment No. 10 to a Schedule 13G/A reporting zero beneficial ownership of Inogen Inc common stock. The filing states an Amount beneficially owned: 0 and Percent of class: 0% as reported in the amendment dated 03/13/2026. The filing explains an internal realignment and disaggregation of Vanguard subsidiaries in accordance with SEC Release No. 34-39538 (January 12, 1998), noting certain subsidiaries now report separate beneficial ownership. The signature on the amendment is dated 03/27/2026 and is signed by Ashley Grim, Head of Global Fund Administration.
Positive
- None.
Negative
- None.
FAQ
What does The Vanguard Group report for INGN in this Schedule 13G/A amendment?
The filing reports 0 shares beneficially owned and 0% of the class for Inogen Inc common stock as of 03/13/2026. It reflects Vanguard's disaggregated reporting after an internal realignment under SEC guidance.
Why does Vanguard state separate reporting for subsidiaries in the amendment?
Vanguard cites SEC Release No. 34-39538 (January 12, 1998), saying certain subsidiaries or business divisions will report beneficial ownership separately following an internal realignment completed on January 12, 2026.
Who signed the Schedule 13G/A amendment for INGN and when?
The amendment is signed by Ashley Grim, Head of Global Fund Administration. The signature line shows the date 03/27/2026, attesting to the reported information in the amendment.
Does the amendment identify any other person with more than 5% ownership in INGN?
The filing states that no other person's interest reported herein is more than 5%. It also notes Vanguard-managed accounts have rights to dividends or proceeds but no single outside person exceeds the five percent threshold.